NCT07090109

PITCH - Impacting Hereditary Cancer Testing

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2027-04Est. Completion: 2027-07

Enrollment target: 200 participants

Locations

Contact

Hormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer

This is a single-center, open-label, randomized phase II clinical trial designed to evaluate the efficacy and safety of …

Guangzhou, ChinaEst. completion Sep 15, 2028

Ovarian Cancer

This is a single site, open label, Phase 1 study using a 3 + 3 dose escalation design in two cohorts of adults with recu…

Palo Alto, United StatesEst. completion Jan 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.